You are currently on the new version of our website. Access the old version .
  • Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
  • Case Report
  • Open Access

15 June 2011

Bacteriologically Confirmed Pulmonary Tuberculosis in a Patient with Lymphangioleiomyomatosis Accompanying Tuberous Sclerosis Syndrome

,
,
,
and
1
I Clinic of Lung Diseases, Institute of Tuberculosis and Lung Diseases, Płocka 26 St., 01-138 Warsaw, Poland
2
Department of Radiology, Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland
3
Department of Microbiology, Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland
*
Author to whom correspondence should be addressed.

Abstract

Lymphangioleiomyomatosis (LAM) is a rare disease of unknown origin, that may be sporadic or develop in the course of tuberous sclerosis (TS). Patients do not present immune deficiency, but structural changes in the lung parenchyma (cysts) may encourage various infections, for example tuberculosis. Radiologic findings are often difficult to interpret, because of changes related to LAM itself. We present a young women with a history of TS and LAM in whom protracted respiratory tract infection was finally diagnosed as tuberculosis. Initial diagnosis was based primarily on clinical signs and symptoms and treatment was started despite a negative result of sputum microscopy for acid-fast bacilli. In the course of treatment, the diagnosis was supported by genetic test for M. tuberculosis in bronchoalveolar lavage fluid, positive tuberculin skin test, interferon-gamma release assay and finally, positive sputum culture in liquid media.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.